Preparation of pyrido[3,2-d]pyrimidines as immunosuppressive agents

Steven De Jonghe; Eduard Dolusic; Ling-Jie Gao; Piet Herdewijn; Wolfgang Pfleiderer

Preparation of pyrido[3,2-d]pyrimidines as immunosuppressive agents

Steven De Jonghe (Inventeur), Eduard Dolusic (Inventeur), Ling-Jie Gao (Inventeur), Piet Herdewijn (Inventeur), Wolfgang Pfleiderer (Inventeur)

Namur Research Institute for Life Sciences

Résultats de recherche: brevet › Brevet

Résumé

This invention relates to substituted pyrido(3,2-d)pyrimidine derivatives, their pharmaceutically acceptable salts, N-oxides, solvates, pro-drugs and enantiomers, possessing unexpectedly desirable pharmaceutical properties, in particular which are highly active immunosuppressive agents, and as such are useful in the treatment in transplant rejection and/or in the treatment of certain inflammatory diseases. These derivatives are also useful in preventing or treating cardiovascular disorders, disorders of the central nervous system, TNF-a related disorders, viral diseases (including hepatitis C)1 erectile dysfunction and cell proliferative disorders.

langue originale	Anglais
Numéro de brevet	WO2009003669 (A2)
CIB	A61K31/519; A61P35/00; C07D471/04
Etat de la publication	Publié - 8 janv. 2009

SDG des Nations Unies

Ce résultat contribue à ou aux Objectifs de développement durable suivants

Empreinte digitale Examiner les sujets de recherche de « Preparation of pyrido[3,2-d]pyrimidines as immunosuppressive agents ». Ensemble, ils forment une empreinte digitale unique.

Contient cette citation

@misc{31f5d63c47b14552839661491864955a,

title = "Preparation of pyrido[3,2-d]pyrimidines as immunosuppressive agents",

abstract = "This invention relates to substituted pyrido(3,2-d)pyrimidine derivatives, their pharmaceutically acceptable salts, N-oxides, solvates, pro-drugs and enantiomers, possessing unexpectedly desirable pharmaceutical properties, in particular which are highly active immunosuppressive agents, and as such are useful in the treatment in transplant rejection and/or in the treatment of certain inflammatory diseases. These derivatives are also useful in preventing or treating cardiovascular disorders, disorders of the central nervous system, TNF-a related disorders, viral diseases (including hepatitis C)1 erectile dysfunction and cell proliferative disorders.",

author = "{De Jonghe}, Steven and Eduard Dolusic and Ling-Jie Gao and Piet Herdewijn and Wolfgang Pfleiderer",

year = "2009",

month = jan,

day = "8",

language = "English",

type = "Patent",

note = "WO2009003669 (A2); A61K31/519; A61P35/00; C07D471/04",

}

TY - PAT

T1 - Preparation of pyrido[3,2-d]pyrimidines as immunosuppressive agents

AU - De Jonghe, Steven

AU - Dolusic, Eduard

AU - Gao, Ling-Jie

AU - Herdewijn, Piet

AU - Pfleiderer, Wolfgang

PY - 2009/1/8

Y1 - 2009/1/8

N2 - This invention relates to substituted pyrido(3,2-d)pyrimidine derivatives, their pharmaceutically acceptable salts, N-oxides, solvates, pro-drugs and enantiomers, possessing unexpectedly desirable pharmaceutical properties, in particular which are highly active immunosuppressive agents, and as such are useful in the treatment in transplant rejection and/or in the treatment of certain inflammatory diseases. These derivatives are also useful in preventing or treating cardiovascular disorders, disorders of the central nervous system, TNF-a related disorders, viral diseases (including hepatitis C)1 erectile dysfunction and cell proliferative disorders.

AB - This invention relates to substituted pyrido(3,2-d)pyrimidine derivatives, their pharmaceutically acceptable salts, N-oxides, solvates, pro-drugs and enantiomers, possessing unexpectedly desirable pharmaceutical properties, in particular which are highly active immunosuppressive agents, and as such are useful in the treatment in transplant rejection and/or in the treatment of certain inflammatory diseases. These derivatives are also useful in preventing or treating cardiovascular disorders, disorders of the central nervous system, TNF-a related disorders, viral diseases (including hepatitis C)1 erectile dysfunction and cell proliferative disorders.

M3 - Patent

M1 - WO2009003669 (A2)

ER -